Thanks for joining us for the 2020 Global Conference on Regulatory Science!
READ MORE
Improving the Process of Therapeutic Development
Harvard, MIT, and the FDA have partnered to create a center focused on regulatory science, bringing together a range of scientific disciplines that are applied to assess the quality, safety and efficacy of medicinal products and inform regulatory decision-making throughout the lifecycle of a medicine. Working across academia, industry, and government institutions, the Center promotes regulatory science through research and education programs, uniting stakeholders under a common mission: promoting optimal patient health outcomes through biomedical innovation and the availability of safe and effective diagnostics and treatments.
Featured Publications
The Regulatory Science Fellowship Program
Our fellowship program is affiliated with the FDA and focuses on training the next generation of regulatory science researchers. Learn more about the research our fellows are conducting or explore opportunities and how to get involved in our program.
Twitter @Harvardmit_CRS
The second presenter at today's #RegSci lab meeting is @nwsusmitha, who explores the ways #nlproc can help with postmarket surveillance of medical devices @Bos_CHIP @ftbourgeois @TMills
The first presentation at today's #RegSci lab meeting is from @GuoXinzhou, who asks, "How good is the combination therapy?" @Bos_CHIP @ftbourgeois
Joining us at today's #RegSci #RegSciForum are Mr. Dov Grossman of Williams & Connolly LLP and Dr. Bruce Chabner, Emeritus Professor @MGHCancerCenter @HarvardMed
Tomorrow @ 8AM, join @UVMMedCenter Dept of Medicine for
"#HeForShe: Recruiting Men in the Fight for #GenderEquity & Inclusion,"
w/ @BrighamWomens' & @harvardmed's Dr Stephanie Mueller & @HarvardMIT_CRS's Dr Michael Sinha
Info at: http://bit.ly/3cZ9zwp
@UVMGenderEquity
Thanks to all who participated in our 3rd Annual @HarvardMIT_CRS Regulatory Science Doctoral Student Symposium, hosted by @arieldora @HarvardHBS! Terrific presentations!